register

News & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Health Industry Hub | December 5, 2023 |

MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, Bird Healthcare, has announced its collaboration with Cystic Fibrosis Australia (CFA).

Cystic fibrosis, a complex condition requiring extensive medical care, therapies, and unwavering support, poses significant challenges for patients and their families. This strategic alliance aims to drive positive change by focusing on improving CF management and outcomes, ultimately striving for a better quality of life for those impacted by this condition.

“This presents a highly promising prospect, and I eagerly anticipate a close working relationship with the team,” expressed Jo Armstrong, CEO of Cystic Fibrosis Australia. “Establishing national corporate partnerships, such as this one, is essential for effectively tackling the major challenges affecting all Australians living with cystic fibrosis.”

Tim Boult, Director of Bird Healthcare, expressed genuine enthusiasm for the collaboration’s potential to create positive outcomes.

“Through our partnership with Cystic Fibrosis Australia, we are confident that we can make a real difference in improving the lives of CF patients and their families. We invite everyone to join us in celebrating this important milestone and supporting the ongoing efforts to raise awareness and financial support for cystic fibrosis,” he stated.

This partnership goes beyond mere collaboration. Bird Healthcare pledges a portion of its profits from their CF range of medical devices to contribute to CFA’s indispensable work in funding research initiatives, advocating for policy changes, and striving for optimal outcomes for Australians living with cystic fibrosis.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.